Skip to main content
Premium Trial:

Request an Annual Quote

Verge Genomics Raises $4M in Seed Financing

NEW YORK (GenomeWeb) – Startup drug discovery firm Verge Genomics today announced it has raised $4 million in seed funding.

IA Ventures led the round, joined by Two Sigma Ventures, Draper Associates, Great Oaks VC, Slow Ventures, Karlin Ventures, and other private investors. San Francisco-based Verge came out of the Y Combinator accelerator and is also a spinout of the University of California, Los Angeles.

The firm is looking to change drug development for neurodegenerative diseases by using algorithms to find the gene networks contributing to those diseases and matching drugs that can affect the entire network.

Verge said in a statement that it will use the proceeds to expand development on its leading algorithmic platform while advancing lead drug candidates through further preclinical proof-of-concept experiments.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.